Volume: May 2024, Issue 1

May 17, 2024 | Hot Topics

AARS News

 

  • AARS Call for Grant Applications

    New Medical Research

    • Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis.
    • The role of vitamins and nutrients in rosacea.
    • Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
    • Resurfacing of atrophic facial acne scars with a multimodality CO2 and 1570 nm laser system.
    • 2% supramolecular salicylic acid hydrogel vs. adapaline gel in mild to moderate acne vulgaris treatment: A multicenter, randomized, evaluator-blind, parallel-controlled trial.
    • Intradermal injection of Cutibacterium acnes and staphylococcus: A pustular acne-like murine model.
    • A meta-analysis of the incidence of acne vulgaris in patients treated with GLP-1 agonists
    • Barriers and facilitators affecting long-term antibiotic prescriptions for acne treatment.
    • Update on combined topical products for treating acne: Leaping from dyads.
    • Pediatric acne vulgaris: A guide for recognition, examination, referral, and treatment.
    • Diagnostic delay in hidradenitis suppurativa: Still an unsolved problem.
    • Comparing the efficacy of topical 4% benzoyl peroxide versus topical 0.1% adapalene for treatment of acne vulgaris in skin of color population: A South Asian perspective.
    • Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: A randomized double-blind clinical trial.

    Clinical Reviews

    • A review of the topical management of acne and its associated sequelae in the Asia-Pacific region with a spotlight on trifarotene.
    • Unveiling the nuances of adult female acne: A comprehensive exploration of epidemiology, treatment modalities, dermocosmetics, and the menopausal influence
    • Saponins of Paris polyphylla for the improvement of acne: Anti-inflammatory, antibacterial, antioxidant and immunomodulatory effects.
    • Acne-induced pathological scars: Pathophysiology and current treatments.
    • Topical clindamycin for acne vulgaris: Analysis of gastrointestinal events.
    • A comprehensive review of the acne grading scale in 2023.
    • Side effects of treating acne vulgaris with isotretinoin: A systematic review.

    Related Posts

    Volume: June 2024, Issue 1

    Volume: June 2024, Issue 1

    AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

    Volume: April 2024, Issue 1

    Volume: April 2024, Issue 1

    AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...

    Volume: March 2024, Issue 1

    Volume: March 2024, Issue 1

    AARS News Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical Research...

    Volume: March 2024, Issue 1

    Volume: February 2024, Issue 1

    AARS News Register now for the 17th Annual AARS Networking Reception Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications AARS Reacts to Acne Treatment Guidelines New Medical Research Prevalence of acne and its impact on quality...